Methods for non-invasive prenatal ploidy calling

US9334541B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9334541-B2
Application numberUS-201414446232-A
CountryUS
Kind codeB2
Filing dateJul 29, 2014
Priority dateMay 18, 2010
Publication dateMay 10, 2016
Grant dateMay 10, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides methods for determining the ploidy status of a chromosome in a gestating fetus from genotypic data measured from a sample of DNA from the mother of the fetus and from the fetus, and from genotypic data from the mother and optionally also from the father. The ploidy state is determined by using a joint distribution model to create a set of expected allele distributions for different possible fetal ploidy states given the parental genotypic data, and comparing the expected allelic distributions to the pattern of measured allelic distributions measured in the mixed sample, and choosing the ploidy state whose expected allelic distribution pattern most closely matches the observed allelic distribution pattern. In an embodiment, the mixed sample of DNA may be preferentially enriched at a plurality of polymorphic loci in a way that minimizes the allelic bias.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for determining the number of copies of a chromosome or chromosome segment of interest in the genome of at least one gestating fetus, the method comprising: sequencing DNA from a first fraction of each mixed sample in a plurality of mixed samples from a plurality of pregnant mothers to obtain a first set of measured genetic data at a plurality of loci on a chromosome or chromosome segment of interest; wherein each mixed sample comprises DNA from a fetus and DNA from the mother of the fetus; generating a plurality of hypotheses specifying the number of copies of the chromosome or chromosome segment of interest in the genome of at least one of the fetuses; determining, on a computer, a first probability for each of the hypotheses using the first set of measured genetic data; sequencing DNA from a second fraction of a least one of the mixed samples for which the first probability of an aneuploid number of copies of the chromosome or chromosome segment of interest is above a threshold value to obtain a second set of measured genetic data at the plurality of loci on the chromosome or chromosome segment of interest; determining, on a computer, a second probability for each of the hypotheses using the second set of measured genetic data and optionally the first set of measured genetic data; selecting the hypothesis with the greatest probability for the second probability determination; and outputting the hypothesis with the greatest probability for the second probability determination as an indication of the number of copies of the chromosome or chromosome segment of interest in the genome of at least one of the fetuses. 2. The method of claim 1 , comprising shotgun sequencing of randomly selected DNA fragments. 3. The method of claim 1 , comprising sequencing non-polymorphic loci. 4. The method of claim 1 , comprising sequencing polymorphic loci. 5. The method of claim 1 , wherein the method further comprises amplifying the DNA prior to sequencing the DNA. 6. The method of claim 1 , comprising: determining, on a computer, allele ratios at polymorphic loci from the measured genetic data; creating, on a computer, a joint distribution model for expected allele ratios of each polymorphic locus for each hypothesis using genetic data from one or both biological parents of at least one of the fetuses; determining, on a computer, the probability of each of the hypotheses using the joint distribution model and the calculated allele ratios; selecting the hypothesis with the greatest probability; and outputting the hypothesis with the greatest probability for the second probability determination as an indication of the number of copies of the chromosome or chromosome segment of interest in the genome of at least one of the fetuses. 7. The method of claim 1 , comprising aggregating the measured genetic data on the chromosome or chromosome segment of interest. 8. The method of claim 1 , comprising determining, on a computer, allele ratios at polymorphic loci from the measured genetic data; aggregating the allele ratios; determining, on a computer, the probability of each of the hypotheses using the aggregated allele ratios; and selecting the hypothesis with the greatest probability; and outputting the hypothesis with the greatest probability for the second probability determination as an indication of the number of copies of the chromosome or chromosome segment of interest in the genome of at least one of the fetuses. 9. The method of claim 7 , wherein determining the number of copies of the chromosome or chromosome segment of interest comprises comparing the aggregated value for the chromosome or chromosome segment of interest to the aggregated value for one or more chromosomes expected to be disomic. 10. The method of claim 1 , wherein determining the number of copies of the chromosome or chromosome segment of interest comprises comparing the total number of sequence reads that map to the chromosome or chromosome segment of interest to the total number of sequence reads that map to one or more other chromosomes. 11. The method of claim 10 , wherein the total number of sequence reads that map to the chromosome or chromosome segment of interest or the total number of sequence reads that map to one or more other chromosomes is adjusted for bias. 12. The method of claim 1 , wherein determining the number of copies of the chromosome or chromosome segment of interest comprises comparing the mean value of sequence reads that map to the chromosome or chromosome segment of interest to the mean value of sequence reads that map to one or more other chromosomes. 13. The method of claim 1 , wherein determining the number of copies of the chromosome or chromosome segment of interest comprises comparing the mean of the allele ratios for the chromosome or chromosome segment of interest to the mean of the allele ratios for one or more other chromosomes. 14. The method of claim 1 , comprising for at least one of the mixed samples: distributing the mixed sample into a plurality of reaction samples to randomly provide individual reaction samples that contain a sequence from the chromosome or chromosome segment of interest and individual reaction samples that do not contain a sequence from the chromosome or chromosome segment of interest; sequencing the DNA in the individual reaction samples to provide a first number of binary results representing presence or absence of a presumably euploid fetal chromosome or chromosome segment in the reaction samples and a second number of binary results representing presence or absence of a possibly aneuploid fetal chromosome or chromosome segment of interest in the reaction samples; determining an expected distribution of a number of binary results for a presumably euploid fetal chromosome or chromosome segment in the reaction samples using the first number; determining an expected distribution of a number of binary results for a presumably aneuploid fetal chromosome or chromosome segment in the reaction samples using the first number and the ratio of fetal to maternal DNA found in the mixed sample; and using a maximum likelihood estimation to select the hypothesis with the greatest probability, thereby determining the number of copies of the chromosome or chromosome segment of interest in the genome of at least one of the fetuses. 15. The method of claim 1 , further comprising determining the ratio of fetal to maternal DNA in each of the mixed samples by calculating a maximum likelihood estimate of the ratio of fetal to maternal DNA. 16. The method of claim 1 , further comprising determining the ratio of fetal to maternal DNA in each of the mixed samples by: identifying polymorphic loci where the father of the fetus has an allele that is not present in the mother of the fetus; and using the amount of the allele possessed by the father but not by the mother in each of the mixed samples for each of the identified polymorphic loci to determine the ratio of fetal to maternal DNA in each of the mixed samples. 17. The method of claim 1 , comprising measuring the difference in methylation between one or more maternal and fetal alleles. 18. The method of claim 1 , wherein determining the number of copies of the chromosome or chromosome segment of interest comprises determining the presence or absence of a deletion or duplication. 19. The method of claim 1 , wherein the mixed samples are isolated from maternal blood. 20. The method of claim 1 , wherein determining the

Assignees

Inventors

Classifications

  • Methods for sequencing · CPC title

  • C12Q1/6883Primary

    for diseases caused by alterations of genetic material · CPC title

  • Primer sets for multiplex assays · CPC title

  • Physics · mapped topic

  • Physics · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9334541B2 cover?
The present disclosure provides methods for determining the ploidy status of a chromosome in a gestating fetus from genotypic data measured from a sample of DNA from the mother of the fetus and from the fetus, and from genotypic data from the mother and optionally also from the father. The ploidy state is determined by using a joint distribution model to create a set of expected allele distribu…
Who is the assignee on this patent?
Natera Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6883. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).